HomeMedicineDiabetesGibtulio Met 12.5/10...
Gibtulio Met 12.5/1000mg Tablet 10'S - Diabetes-Ant
  • Gibtulio Met 12.5/1000mg Tablet 10'S - Diabetes-Ant
View previous image
View next image
Gibtulio Met 12.5/1000mg Tablet 10'S - Diabetes-Ant
GST Benefits New Revised MRP, 100% GST benefit passed
Lupin Ltd

Gibtulio Met 12.5/1000mg Tablet 10'S

Diabetes
MRP ₹150.94 (Inclusive of all taxes)
Deliver to

    Netmeds First Membership

    Starting at just ₹[] for 3 months.
    View Plans

    Quick Links

    Uses|How it works|Directions for use|Side effects|Warning & precautions|Interactions|Synopsis|Useful diagnostic tests

    Introduction About GIBTULIO MET 12.5/1000MG TABLET

    GIBTULIO MET 12.5/1000MG TABLET is a combination of Empagliflozin and Metformin which belongs to the group of medicines called Antidiabetic agents. GIBTULIO MET 12.5/1000MG TABLET is indicated for the management of type II diabetes mellitus in addition to diet and exercise among adults who remain unresponsive to therapy with either metformin alone or in combination with other antidiabetic medicines.   

    GIBTULIO MET 12.5/1000MG TABLET can also be used in combination with other medicines (including insulin) to achieve better control of blood sugar level. Type 2 diabetes is a chronic medical condition in which the body does not make enough insulin or the produced insulin does not work well. Symptoms include excessive urination, excessive thirst, hunger, fatigue and blurred vision.

    Along management with GIBTULIO MET 12.5/1000MG TABLET follow regular exercise and diet plan as advised by your doctor to achieve better results. Avoid consumption of alcohol during management with GIBTULIO MET 12.5/1000MG TABLET as it could aggravate your existing disease condition.    

    Management with GIBTULIO MET 12.5/1000MG TABLET must be discontinued for a short time, if you have any conditions that may be associated with dehydration (such as vomiting, diarrhea, fever, exposure to heat or less fluid intake). During management with GIBTULIO MET 12.5/1000MG TABLET, your doctor will check your kidney function at least once a year or more frequently especially if you are elderly.

    For diabetic patients, it is recommended to check their foot regularly and adhere to any other advice regarding foot care given by your doctor. GIBTULIO MET 12.5/1000MG TABLET is generally not recommended for use in pregnant or breastfeeding women, including children and adolescents (aged less than 18 years) due to lack of safety data.

    The most common side effects of taking GIBTULIO MET 12.5/1000MG TABLET are hypoglycemia (low blood glucose), nausea, vomiting, diarrhea, excessive thirst, change in taste or dizziness. Consult your doctor if any of the side effects worsen.

    Uses Of GIBTULIO MET 12.5/1000MG TABLET

    • To manage type II diabetes mellitus in addition to diet and exercise among adults who remain unresponsive to therapy with either metformin alone or in combination with other antidiabetic medicines

    How GIBTULIO MET 12.5/1000MG TABLET Works

    GIBTULIO MET 12.5/1000MG TABLET effectively reduces blood glucose levels, where empagliflozin acts by blocking the activity of a protein called sodium glucose co-transporter 2, which is responsible for the tubular reabsorption of glucose into the blood stream and metformin acts by reducing the amount of glucose released into the blood stream by the liver, thus helps in reducing blood glucose levels.

    How to use GIBTULIO MET 12.5/1000MG TABLET

    Always take GIBTULIO MET 12.5/1000MG TABLET as directed by your physician. Swallow the medicine as a whole and do not crush or chew the medicine. Your doctor will decide the correct dose and duration for you depending upon your age, body weight and disease condition. Do not stop taking GIBTULIO MET 12.5/1000MG TABLET without informing your doctor.

    Side Effects Of GIBTULIO MET 12.5/1000MG TABLET

    Common

    • signs of low blood glucose levels (such as excessive hunger, headache, shaking, sweating, confusion, anxiety, fast heartbeat)
    • urinary tract infection (pain or burning sensation while passing urine, cloudy urine, frequent urination, pain in the pelvis or mid-back pain)
    • dehydration (unusual thirst, fainting or loss of consciousness, lightheadedness or dizziness upon standing)
    • nausea, vomiting, diarrhea, constipation, stomach pain or loss of appetite
    • thrush (genital yeast infection)
    • skin rash, redness or itching with raised bumps or blisters
    • change in taste
    • excessive thirst

    Uncommon

    • hives (raised itchy welts on the skin)
    • painful urination

    Stop taking GIBTULIO MET 12.5/1000MG TABLET and contact your doctor immediately if you experience any of the following side effects:

    • severe allergic reactions (such as swelling of the face, lips, mouth, tongue or throat that may lead to difficulty in breathing or swallowing)
    • symptoms of lactic acidosis (such as vomiting, stomach pain, decreased heartbeat, difficulty in breathing, muscle cramps, general weakness with severe tiredness or reduced body temperature)
    • symptoms of diabetic ketoacidosis (such as nausea, vomiting, rapid weight loss, stomach pain, excessive thirst, fast and deep breathing, unusual sleepiness or tiredness, confusion, a sweet smell in your breath, a sweet or metallic taste in your mouth or a different odor to your urine or sweat)
    • symptoms of fournier´s gangrene (such as pain, tenderness, redness or swelling of genitals or area between the genitals and the anus accompanied with fever or general weakness)

    How To Manage Side Effects

    Constipation

    Take fiber rich foods in your diet such as vegetables, whole grain cereals and drink plenty of fluids. Exercise more regularly and stay active. Consult your doctor if the symptom did not improve.

    Diarrhea

    Drink lot of fluids such as water or fruit juices to keep yourself hydrated. Avoid taking any medicine on your own for managing diarrhea. Consult your doctor if the symptom did not improve.

    Loss Of Appetite

    Eat when you are hungry. Eat smaller meals more often than usual. Snack only when you're hungry. Try to have a nutritious snack that is rich in calories and protein such as dried fruit and nuts. Consult your doctor if the symptom did not improve.

    Nausea And Vomiting

    Stick to simple meals while taking this medicine. Avoid eating oil rich or spicy foods. Consult your doctor if the symptom did not improve.

    Skin rash Or Itching

    Avoid hot showers because hot water can irritate your skin further. Do not scratch the affected area. Use protective clothing when going outdoors. Regularly moisturize your skin. Consult your doctor if the symptom did not improve.

    Stomach Pain

    Rest and relax. Eat and drink slowly or try to have smaller and frequent meals. Keep a heat pad on your stomach. Do not self-manage on your own and consult your doctor if the symptom did not improve on its own.

    Warning & Precautions

    Pregnancy

    Contraindicated

    GIBTULIO MET 12.5/1000MG TABLET is not recommended for use in pregnant women. Consult your doctor before taking GIBTULIO MET 12.5/1000MG TABLET. 

    Breastfeeding

    Contraindicated

    GIBTULIO MET 12.5/1000MG TABLET is not recommended for use in breastfeeding women. Consult your doctor before taking GIBTULIO MET 12.5/1000MG TABLET.

    Driving and Using Machines

    Use with Caution

    Do not drive or operate any tools or machines if you experience dizziness after taking GIBTULIO MET 12.5/1000MG TABLET.

    Alcohol

    Consult your doctor

    Avoid consumption of alcohol while taking GIBTULIO MET 12.5/1000MG TABLET since it may increase the risk of lactic acidosis.

    Kidney

    Contraindicated

    GIBTULIO MET 12.5/1000MG TABLET is not recommended for use in patients with severe kidney disease. Consult your doctor before taking GIBTULIO MET 12.5/1000MG TABLET.

    Liver

    Contraindicated

    GIBTULIO MET 12.5/1000MG TABLET is not recommended for use in patients with liver problems. Consult your doctor before taking GIBTULIO MET 12.5/1000MG TABLET.

    Allergy

    Contraindicated

    Do not take GIBTULIO MET 12.5/1000MG TABLET if you are allergic to Empagliflozin or Metformin.

    Heart Disease

    Contraindicated

    GIBTULIO MET 12.5/1000MG TABLET is not recommended for use in patients with heart problems (such as recent heart attack or failure, cardiogenic shock (problems in blood circulation) or abnormal breathing). Consult your doctor before taking GIBTULIO MET 12.5/1000MG TABLET.

    Use In Pediatrics

    Contraindicated

    GIBTULIO MET 12.5/1000MG TABLET is generally not recommended for use in children and adolescents (under 18 years of age). Consult your child’s doctor for advice.

    Use In Geriatrics

    Use with Caution

    GIBTULIO MET 12.5/1000MG TABLET should be used with caution in elderly patients (aged 65 years or above). Your doctor may assess your kidney function more frequently during management with GIBTULIO MET 12.5/1000MG TABLET. Consult your doctor before taking GIBTULIO MET 12.5/1000MG TABLET.

    Others

    GIBTULIO MET 12.5/1000MG TABLET is not recommended for use if you:

    • have uncontrolled diabetes with nausea, vomiting, rapid weight loss, diarrhea, lactic acidosis (lactic acid build up in the bloodstream) or ketoacidosis (ketone bodies accumulate in the blood)
    • have ever had a diabetic pre-coma
    • have severe systemic infections affecting your lungs or kidneys
    • have severe dehydration (either due to vomiting or diarrhea)
    • are alcoholic
    • have type I diabetes
    • have an upcoming major surgery

    Before taking GIBTULIO MET 12.5/1000MG TABLET inform your doctor if you:

    • need to undergo an examination with iodination contrast agents (Ex. X-ray or scan)

    Interactions

    A. Drug-Drug interactions:

    Before taking GIBTULIO MET 12.5/1000MG TABLET inform to your doctor, if you are taking any of these medicines:

    • diuretics (medicines used to increase urine output) Ex. furosemide, chlorothiazide, hydrochlorothiazide
    • other medicines used to manage diabetes (Ex. insulin, glipizide, glyburide, glimepiride)
    • cimetidine (used to manage stomach ulcers)
    • verapamil, ranolazine (used to manage chest pain)
    • dolutegravir (used to manage HIV infection)
    • trimethoprim (used to manage bacterial infection)
    • isavuconazole (used to manage fungal infection)
    • crizotinib, olaparib, vandetanib (used to manage certain forms of cancer)
    • bronchodilators (used to manage asthma) Ex. salbutamol, salmeterol, formoterol, ipratropium
    • corticosteroids (used to manage inflammation) Ex. dexamethasone, prednisolone
    • medicines used to manage pain and inflammation (such as ibuprofen and celecoxib)
    • medicines used to manage high blood pressure (Ex. captopril, enalapril, losartan, valsartan)
    • medicines containing alcohol (such as cough syrup)
    • iodinated contrast agents (used during an X-ray or scan)
    • lithium (used to manage mental illness)

    Overdosage:

    If you or anyone else accidentally take too much of GIBTULIO MET 12.5/1000MG TABLET, contact your doctor immediately or go to a nearest hospital straight away as it could lead to a life-threatening condition called lactic acidosis. Symptoms of lactic acidosis might include nausea, vomiting, stomach pain with muscle cramps, decreased heartbeat, general weakness with severe tiredness, difficulty in breathing or reduced body temperature.

    Synopsis

    Drug :   Empagliflozin, Metformin
    Pharmacological Category :   Sodium-glucose co-transporter 2 (SGLT2) inhibitors; Biguanides
    Therapeutic Indication :   Type II diabetes mellitus
    Dosage Forms :   Tablet

    More Information

    • Keep GIBTULIO MET 12.5/1000MG TABLET out of reach of children
    • Store at room temperature

    FAQs About GIBTULIO MET 12.5/1000MG TABLET

    Q: Can I consume alcohol while taking GIBTULIO MET 12.5/1000MG TABLET?

    A: No, avoid consumption of alcohol while taking GIBTULIO MET 12.5/1000MG TABLET since it may increase the risk of lactic acidosis and diabetic ketoacidosis. Before taking GIBTULIO MET 12.5/1000MG TABLET inform your doctor if you are alcoholic.  

    Q: Can GIBTULIO MET 12.5/1000MG TABLET makes me feel more tired?

    A: Yes, GIBTULIO MET 12.5/1000MG TABLET can cause severe tiredness, unusual thirst, lightheadedness or dizziness upon standing in some individuals. Consult your doctor immediately if you experience any unusual symptoms after taking GIBTULIO MET 12.5/1000MG TABLET.  

    Q: Is GIBTULIO MET 12.5/1000MG TABLET safe to use in elderly patients?

    A: GIBTULIO MET 12.5/1000MG TABLET should be used with caution in elderly patients (aged 65 years or above), consult your doctor before taking GIBTULIO MET 12.5/1000MG TABLET. Your doctor might check your kidney function at least once a year or more frequently to avoid kidney damage. 

    Q: Can GIBTULIO MET 12.5/1000MG TABLET be used in patients with heart disease?

    A: GIBTULIO MET 12.5/1000MG TABLET is not recommended for use in patients with heart problems such as recent heart attack or failure, cardiogenic shock (problems in blood circulation) or abnormal breathing. Consult your doctor before taking GIBTULIO MET 12.5/1000MG TABLET.    

    Q: What is GIBTULIO MET 12.5/1000MG TABLET used for?

    A: GIBTULIO MET 12.5/1000MG TABLET is used to manage type II diabetes mellitus in addition to diet and exercise among adults who remain unresponsive to therapy with either metformin alone or in combination with other antidiabetic medicines. It is not recommended for use in patients with type-1 diabetes.

    References

    1. KD. Tripathi. Insulin, Oral Hypoglycemic Drugs and Glucagon. Essentials of medical pharmacology. Seventh edition. 2013. Page – 275-276 & 278.

    2. Gerald G. Briggs and Roger K. Freeman. A reference guide to fetal and neonatal risk: Drugs in Pregnancy and Lactation. Tenth Edition. 2015. Page – 2451-2456.

    3. Boehringer Ingelheim. Safety and Efficacy Study of Empagliflozin and Metformin for 24 Weeks in Treatment Naive Patients with Type 2 Diabetes. NIH U.S. National Library of Medicine ClinicalTrials.gov. [Revised in February 2016] [Accessed on 27th November 2023] https://clinicaltrials.gov/ct2/show/NCT01719003

    4. Boehringer Ingelheim. Efficacy and Safety of Empagliflozin (BI 10773) With Metformin in Patients with Type 2 Diabetes. NIH U.S. National Library of Medicine ClinicalTrials.gov. [Revised in September 2016] [Accessed on 27th November 2023] https://clinicaltrials.gov/ct2/show/NCT01167881

    5. Jennifer D Goldman. Combination of Empagliflozin and Metformin Therapy: A Consideration of its Place in Type 2 Diabetes Therapy. NCBI; PMC US National Library of Medicine, National Institute of Health. July 2018. [Accessed on 27th November 2023] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6043932/

    6. Matthew J. Levine. Empagliflozin for Type 2 Diabetes Mellitus: An Overview of Phase 3 Clinical Trials. NCBI; PMC US National Library of Medicine, National Institute of Health. August 2017. [Accessed on 27th November 2023] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5543566/

    7. Uche Anadu Ndefo, Nicole O. Anidiobi, Efrah Basheer and Angie T. Eaton. Empagliflozin (Jardiance): A Novel SGLT2 Inhibitor for the Treatment of Type-2 Diabetes. NCBI; PMC US National Library of Medicine, National Institute of Health. June 2015. [Accessed on 27th November 2023] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4450666/

    8. Samy Hadjadj, Julio Rosenstock, Thomas Meinicke, Hans J Woerle, Uli C Broedl. Initial Combination of Empagliflozin and Metformin in Patients with Type 2 Diabetes. NIH National Library of Medicine, National center for biotechnology information. Pubmed.gov. October 2016. [Accessed on 27th November 2023] https://pubmed.ncbi.nlm.nih.gov/27493136/

    9. Boehringer Ingelheim Pharma GmbH & Co. KG. Electronic Medicines Compendium (EMC). [Revised in January 2021] [Accessed on 27th November 2023] https://www.medicines.org.uk/emc/files/pil.11420.pdf

    11. Boehringer Ingelheim Pharmaceuticals, Inc. U.S. Food & Drug Administration. [Revised in December 2016] [Accessed on 27th November 2023] https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/206111s004lbl.pdf

     

    Useful Diagnostic Tests

    • HbA1C, Also known as Glycated Hemoglobin, Glycosylated Hemoglobin
    • Blood Glucose Fasting (FBS)
    • Random Blood Sugar (Rbs)
    • Post Prandial Blood Sugar (PPBS)
    • Comprehensive Diabetes Care
    • Diabetes Screening
    • Diabetic Profile – Advanced
    • Diabetes Care Package
    • Healthians Diabetic Checkup

    Author Details

    Written By Dr. R. Dinesh John Rajkumar - Pharm.D
    Reviewed For Accuracy By Dr. Jaya Prabakaran - MBBS, MD (Diabetology and Family Medicine)
    Last updated on 27 Nov 2023 | 06:06 PM(IST)
    Lab updated